Atlas Trials

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Clinical trial NCT02021825 · UNKNOWN

Trial details

NCT number
NCT02021825
Sponsor
Xuanwu Hospital, Beijing
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorders
Start date
2009-03-01
Primary completion
2014-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.